Advertisement

Topics

FivePrime Nabs Partner, Solazyme’s $100M IPO Plan, Where Blockbuster Drugs Come From, & More Bay Area Life Sciences News

05:10 EDT 18 Mar 2011 |

I was a teensy bit preoccupied this week organizing and moderating our first life sciences event this week at Xconomy San Francisco, but managed to keep up with a few of the big headlines that crossed my desk. —FivePrime Therapeutics, the South San Francisco-based developer of protein drugs, said this week it struck a deal [...]

Original Article: FivePrime Nabs Partner, Solazyme’s $100M IPO Plan, Where Blockbuster Drugs Come From, & More Bay Area Life Sciences News

NEXT ARTICLE

More From BioPortfolio on "FivePrime Nabs Partner, Solazyme’s $100M IPO Plan, Where Blockbuster Drugs Come From, & More Bay Area Life Sciences News"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...